THE BUZ ON CANNABIS STOCK




Cannabis Stock 

CANNABIS BUZZ Pure play marijuana stocks are scarce. Most companies in the marijuana industry trade over the counter (OTC), where solid information regarding operations and financials is difficult to retrieve. Exceptions extend to issues such as GW Pharmaceuticals plc (NASDAQ: GWPH), a British biopharmaceutical company that developed two cannabis-based drugs licensed for use outside the United States. Sativex is used to treat muscular contractions in multiple sclerosis patients, and Epidiolex targets epileptic seizures in children. Both drugs have entered Phase 3 clinical stage trials in the United States. GWPH has a $2 billion market cap and had returned 23% year to date (YTD) as of Aug. 15, 2016.

Political and legal obstacles remain the highest hurdles for the marijuana industry in 2016. Four states, Oregon, Washington, Alaska and Colorado, have legalized recreational marijuana, and 25 states plus the District of Columbia have approved cannabis for medicinal purposes. The plant is categorized at the federal level as a Schedule 1 drug, possessing the highest risk for psychological and physical dependence, and more curiously, having no acceptable medical use.

Emblem To Disrupt $60 Billion Opiod Market With Cannabis Based Sustained Release Formulation Symbol: EMC  Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Company”) announced today that it has entered into a Collaboration and Licensing Agreement (the “Agreement”) with Canntab Therapeutics Limited (“Canntab”) of Toronto. Canntab has developed a patent-pending oral sustained release formulation for cannabinoids
Complete Reading

Emblem Announces Exclusive Agreement with Canntab Therapeutics for Cannabinoid Based Oral Sustained Release Formulation    Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Company”) announced today that it has entered into a Collaboration and Licensing Agreement (the “Agreement”) with Canntab Therapeutics Limited (“Canntab”) of Toronto. Canntab has developed a patent-pending oral sustained release formulation for cannabinoids
Complete Reading

Medicinal Marijuana Stocks vs. Recreational Marijuana Stocks  Top Marijuana Stocks With all the excitement that’s building up over the coming marijuana legalization in several states across the U.S. and nationwide in Canada, it’s easy to get caught up in the hype surrounding the recreational marijuana business. But as we all know, in the stock market,
Complete Reading

GT Biopharma, Inc. Announces Corporate Update Conference Call with CEO Dr. Kathleen Clarence-Smith, CMO Dr. Raymond Urbanski and Chairman Anthony Cataldo GT Biopharma Inc. (GTBP), a targeted immunotherapies company with close to market treatments for Central Nervous System (CNS) diseases (neurology and pain), will hold a conference call, hosted by www.biotechstocks.com, to discuss advancements made with
Complete Reading

Hemp, Inc. Announces Exclusive “First Friday Tours” of its Industrial Hemp Processing Facility and Milling Operation Hemp, Inc. ( OTC PINK : HEMP ) – Curious about the largest industrial hemp processing facility in the western hemisphere and its operation? Hemp, Inc. shareholders can now get an in-depth look by attending exclusive “First Friday Tours” of Hemp, Inc.’s expanded industrial hemp processing
Complete Reading

Create Account



Log In Your Account



Dash_En